Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer Treatment Reviews

• Publication date

  1987-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0305-7372(87)90024-7PMID 3326668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

  1988cited by this paper
• Potential of Sugar Residues Attached to N-(2- Hydroxypropyl)methacryl amide Copolymers as Targeting Groups for the Selective Delivery of Drugs

  1987cited by this paper
• COPOLYMERS OF 6-O-METHACRYLOYL-D-GALACTOSE AND N-(2-HYDROXYPROPYL)METHACRYLAMIDE: TARGETING TO LIVER AFTER INTRAVENOUS ADMINISTRATION TO RATS.

  1987cited by this paper
• Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.

  1987cited by this paper
• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.

  1987cited by this paper
• Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.

  1986cited by this paper
• Use of polysaccharides as drug carriers. Dextran and inulin derivatives of procainamide.

  1985cited by this paper
• Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

  1985cited by this paper
• Immunogenicity of N‐(2‐hydroxypropyl) methacrylamide copolymers

  1985cited by this paper
• Dextran and Inulin Derivatives of Procainamide

  1985cited by this paper
• Uptake and Intracellular Processing of Targeted and Nontargeted Liposomes by Rat Kupffer Cells In Vivo and In Vitro a

  1985cited by this paper
• Soluble synthetic polymers as potential drug carriers

  1984cited by this paper
• Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting

  1984cited by this paper
• Quantitative role of parenchymal and non-parenchymal liver cells in the uptake of [14C]sucrose-labelled low-density lipoprotein in vivo.

  1984cited by this paper
• Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitro

  1983cited by this paper
• Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.

  1983cited by this paper
• Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N‐(2‐hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B

  1983cited by this paper
• Polymeric carriers of glycerol derivatives, 2. Chlorambucil derivatives†

  1983cited by this paper
• Liposome targeting in vivo: Problems and opportunities

  1983cited by this paper
• Development of N-(2-Hydroxypropyl)Methacrylamide Copolymers as Carriers of Therapeutic Agents

  1983cited by this paper
• The anticancer agent adriamycin can be actively cytotoxic without entering cells.

  1982cited by this paper
• Anti‐tumor activity of daunorubicin linked to poly‐L‐aspartic acid

  1982cited by this paper
• In Vitro and In Vivo Efficacy of Conjugates of Daunomycin with Anti‐Tumor Antibodies

  1982cited by this paper
• Use of antibodies against tumor-associated antigens for cancer diagnosis and treatment.

  1981cited by this paper
• Synthesis of polydienes of controlled tacticity with new catalytic systems

  1981cited by this paper
• Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.

  1979cited by this paper
• Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

  1977cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Chemotherapy through lysosomes with a DNA-daunorubicin complex.

  1972cited by this paper

• Nanomedicine for the Treatment of Advanced Prostate Cancer

  2020cites this paper
• Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines.

  2020cites this paper
• TransitionCells in Response to Its Hyperthermia-mediated Phase Enhanced Uptake of a Thermally Responsive Polypeptide by

  2013cites this paper
• Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.

  2008cites this paper
• N-(2-Hydroxylpropyl)-Methacrylamide–Attached Doxorubicin Induces Cytotoxicity to Prostate Cancer Cell Line DU145

  2008cites this paper
• Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide

  2008cites this paper
• Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.

  2007cites this paper
• Controlled Drug Delivery : Transition to Nanosystems

  2006cites this paper
• Targeted Drug Delivery in Cancer Therapy

  2005cites this paper
• Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy

  2005cites this paper
• Dendritic Poly-[N-(2-Hydroxyethyl)-L-Glutamine] as Potential Drug Carrier

  2004cites this paper
• Scintigraphic evaluation of the pharmacokinetics of a soluble polymeric drug carrier

  2004cites this paper
• Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts

  2004cites this paper
• Synthesis and properties of branched chemodegradable polymers based on N-vinylpyrrollidone and N-(2-hydroxypropyl)methacrylamide, carriers of biologically active compounds

  2004cites this paper
• Targeted Drug Delivery to Tumor Cells Using Colloidal Carriers

  2004cites this paper
• Degree of substitution of chlorin $e_{6}$ on charged poly- L-lysine chains affects their cellular uptake, localization and phototoxicity towards macrophages and cancer cells

  2002cites this paper
• Targeted drug delivery by thermally responsive polymers.

  2002cites this paper
• Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.

  2001cites this paper
• Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.

  2000cites this paper
• In vivo fluorescence imaging of the transport of charged chlorine6 conjugates in a rat orthotopic prostate tumour

  1999cites this paper
• Polymer water-soluble derivatives of polypeptide antibiotic, gramicidin-S based on reactive copolymers of N-(2-hydroxypropyl) methacrylamide.

  1999cites this paper
• The Effect of Charge on Cellular Uptake and Phototoxicity of Polylysine Chlorine6Conjugates

  1997cites this paper
• Penetration of Polymeric Drug Carriers into K562 Cells

  1996cites this paper
• 111In labelling of a branched polypeptide drug carrier with a poly(L-lysine) backbone

  1992cites this paper
• Passive tumor targeting of soluble macromolecules and drug conjugates.

  1992cites this paper
• Polymethylmethacrylate-antiblastic drug compounds: an in vitro study assessing the cytotoxic effect in cancer cell lines--a new method for local chemotherapy of bone metastasis.

  1992cites this paper
• Doxorubicin-3'-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomes.

  1990cites this paper
• Immunogenicity of Protein-N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates in A/J and B10 Mice

  1990cites this paper
• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo

  1989cites this paper
• Poly(carboxylic acid) polymers as carriers for anthracyclines

  1989cites this paper
• Soluble Synthetic Polymers for Targeting and Controlled Release of Anticancer Agents, Particularly Anthracycline Antibiotics

  1988cites this paper